Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

NCT06588517 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Pirfenidone Modified-Release Tablets
DRUG: Pirfenidone Tablets

Sponsor

Overseas Pharmaceuticals, Ltd.

Collaborators

[object Object]